Terifrac 750 Mcg Injection

$Terifrac 750 Mcg Injection$

$Terifrac 750 Mcg Injection Share$

Terifrac 750 Mcg Injection Specification

Brand Name
Terifrac

Salt Composition
Teriparatide 750 mcg

Life Span
24 months from date of manufacture

Packaging Type
Prefilled Syringe

Pacakaging (Quantity Per Box)
1 prefilled syringe

Indication
Osteoporosis in postmenopausal women and men at increased risk of fracture

Dosage Form
Injection

Origin of Medicine
India

Drug Type
Injection

Ingredients
Teriparatide 750 mcg

Physical Form
Liquid

Function
Promotes bone formation; treats osteoporosis

Recommended For
Patients with osteoporosis, individuals at high risk of fractures

Dosage
As directed by the physician, typically 20 mcg once daily

Dosage Guidelines
As per the doctor's advice

Suitable For
Adults

Quantity
3 ml

Storage Instructions
Keep at cool and Dry Place

Strength
750 mcg/3 ml

Shelf Life After Opening
Use within 28 days

Prescription Required
Yes

Appearance
Clear, colorless solution

Side Effects
Possible side effects include nausea, joint pain, dizziness

Route of Administration
Subcutaneous

Special Precautions
Do not shake; use under medical supervision only

Regulatory Approval
DCGI Approved

Contraindications
Not for use in pediatric patients, pregnant or lactating women

Inactive Ingredients
Mannitol, acetic acid, sodium acetate, metacresol, water for injection

Available Strengths
750 mcg

Terifrac 750 Mcg Injection Trade Information

Minimum Order Quantity
100 Pieces

Payment Terms
Paypal, Cash Advance (CA), Cheque

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Terifrac 750 Mcg Injection

Spotlight on the monumental Terifrac 750 Mcg Injection, a top-tier, hot-selling solution for osteoporosis management. This splendiferous product, by renowned Brand Terifrac from India, features DCGI-approved, excellent-quality Teriparatide 750 mcg in a clear, colorless prefilled syringe. Specially crafted for adults at high fracture risk, Terifrac promotes robust bone formation. With a 24-month shelf life and superior packaging (1 prefilled syringe per box), it ensures both potency and safety. Always use under medical supervision, as directed by a physician. Not suitable for children, pregnant, or lactating women.

Distinguished Application and Features

Terifrac 750 Mcg Injection is meticulously engineered for treating osteoporosis in postmenopausal women and men facing a high risk of fractures. Its area of application spans orthopedic and endocrinological settings, administered subcutaneously for optimal bone health. The solution's clarity underlines its pharmaceutical excellence. Prefilled syringes guarantee precise dosing, while its formulation ensures swift absorption and efficacy. This injection stands as a reliable option for healthcare providers managing osteoporosis in adults.

Delivery, Export Market, and Packaging Advantages

Terifrac 750 Mcg Injection is packaged in premium prefilled syringes, ensuring product integrity and ease of administration. With a substantial export market footprint, this product is supplied to wholesalers and exporters across diverse international regions. Delivery times vary by destination, typically ranging from prompt to expedited shipping, ensuring minimal lag for health expenditure needs. Samples may be available upon request, supporting client confidence and transparency in quality before procurement.

FAQ's of Terifrac 750 Mcg Injection:

Q: How should Terifrac 750 Mcg Injection be used for osteoporosis treatment?

A: Terifrac 750 Mcg Injection should be administered subcutaneously as directed by a physician, typically 20 mcg once daily, and only under strict medical supervision.

Q: What are the primary benefits of Terifrac 750 Mcg Injection?

A: It is highly effective in promoting bone formation and treating osteoporosis in adults at increased risk of bone fractures, empowering patients toward better bone health.

Q: When should I start using Terifrac 750 Mcg Injection?

A: Start Terifrac only after your healthcare provider prescribes it, following a proper diagnosis of osteoporosis or a demonstrated high risk of fractures.

Q: Where should the Terifrac 750 Mcg Injection be stored after opening?

A: Store the injection in a cool and dry place. After opening, use it within 28 days while keeping it refrigerated as per medical advice.

Q: What precautions must be taken during the usage of Terifrac 750 Mcg Injection?

A: Do not shake the injection, and always use it under the supervision of a healthcare professional. It is not recommended for pediatric patients, or for pregnant or lactating women.